HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

Cigna Sees Cost Savings, Improved Member Engagement in Study

Cigna is seeing notable savings and improved member engagement through its integrated benefits plans, according to a new study. On average, these plans saved $227 annually per member, and, for members who have an identified opportunity to improve their health, savings were $4,741 per member […]

more info 01/20/2021View Related Articles
Bookmark and Share

Using Real World Data to Close Rare Disease Gap

Rare disease research and treatment development is uniquely challenging given the limited understanding of rare and genetic diseases. De-identified, real-world data (RWD) features claims and electronic health record (EHR) data. Read how this robust, longitudinal patient view makes RWD an invaluable […]

more info 01/20/2021View Related Articles
Bookmark and Share

xCures Announces Collaboration with CancerCompass

Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures' platform and services.Consumers who purchase xCures’ comprehensive cancer case review service benefit from the xCures team organizing and structuring their medical […]

more info 01/20/2021View Related Articles
Bookmark and Share

Komodo Health Acquires Mavens

Today, Komodo Health announced the acquisition of Mavens, a leader and pioneer in cloud-based technology solutions for life sciences. The acquisition brings together two best-in-class technology companies, expands our suite of enterprise applications, and creates a transformational enterprise […]

more info 01/20/2021View Related Articles
Bookmark and Share

Associate Editor Roles – IJTAHC

The International Journal of Technology Assessment in Health Care (IJTAHC) is a journal of Cambridge University Press and a key platform for the Society, Health Technology Assessment International (HTAi). We are calling for new Associate Editors to participate in the editorial process and develop […]

more info 01/20/2021View Related Articles
Bookmark and Share

How a Former Health Care Executive Became a Health Care Whistleblower

Former health care executive Wendell Potter spent part of 2020 publishing high-profile apologies for the work he used to do — the lies he said he told the American people for his old employers. These days, he said, he’s also trying to debunk myths he once sold. “What I used to do for a living was […]

more info 01/19/2021View Related Articles
Bookmark and Share

COVID-19 Trial Tracker Updates

In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders. Funded in part by The Bill and Melinda Gates Foundation, a leader […]

more info 01/19/2021View Related Articles
Bookmark and Share

(Podcast) Bridge the City: Opportunity Costs of Healthcare in the US

Researchers David Vanness and James Lomas joined the Bridge the City podcast to explain the conclusions of their new paper, "A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States." They describe how pharmaceutical products whose prices do not represent good value […]

more info 01/19/2021View Related Articles
Bookmark and Share

[Podcast] How Doctors Can Be a Part of the Solution

In the final episode of our podcast's inaugural season, neurologist Jason Crowell and ICER's President Steve Pearson discuss what physicians can do in their hospitals and communities to advocate for fair drug prices, and they explore what questions doctors should ask patients to assess for financial […]

more info 01/19/2021View Related Articles
Bookmark and Share

3 Ways That Payers Leveraged Artificial Intelligence in 2020

Payers used artificial intelligence to drive towards key objectives in 2020. Artificial intelligence is not a new technology, with the first artificial intelligence programs emerging in the early 1950s. However, payers, providers, and vendors continue to enhance and specialize this technology to […]

more info 01/19/2021View Related Articles
Bookmark and Share

Aligning HEOR/RWE Procurement with Finance

Procurement is a business function that offers so much in the way of value. However, its not always easy to showcase the full spectrum of what procurement provides to other teams or get the necessary buy-in from sponsors or stakeholders to support procurement activities. In fact, one of the common […]

more info 01/19/2021View Related Articles
Bookmark and Share

State Level Action in Response to ICER’s Unsupported Price Increase Report

In ICER’s latest report on Unsupported Price Increases (UPI), we determined that 7 of the 10 costliest US drug-price hikes in 2019 lacked new evidence of a previously unknown clinical benefit. Even after accounting for rebates, the unsupported price increases on just these 7 drugs cost Americans an […]

more info 01/18/2021View Related Articles
Bookmark and Share

Janet Woodcock to be Acting FDA Commissioner

Janet Woodcock is set to be the most powerful person at the FDA in less than a week. The veteran regulator and longtime director of the Center for Drug Evaluation and Research has been tapped as acting commissioner of the FDA, according to reports by BioCentury’s Steve Usdin and Pink Sheet’s Sarah […]

more info 01/18/2021View Related Articles
Bookmark and Share

Amgen Tops Cost Watchdog’s Price Gougers List

In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s naughty list with “unsupported” markups that added as much as $403 million to the nation’s drug spend during that time. Price increases for some of pharma’s most popular drugs have long […]

more info 01/18/2021View Related Articles
Bookmark and Share

The American Public’s Priorities for the New President and Congress

In a post-election Politico/Harvard poll, an overwhelming 87% of the respondents indicated that “taking federal government action to lower prescription drug prices” should be an extremely important priority for the federal government. The only issue that ranked higher was enacting a major COVID-19 […]

more info 01/18/2021View Related Articles
Bookmark and Share

Webinar: Pathways to ISPOR Leadership

Tune in to the next installment of our leadership development series “Pathways to ISPOR Leadership” with special guest Mike Drummond, PhD, Professor of Health Economics, Centre for Health Economics, University of York. This webinar will take place Tuesday, January 26, 2021 from 11:00AM - 11:45AM […]

more info 01/18/2021View Related Articles
Bookmark and Share

Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017

A new analysis from the US Government Accountability Office shows that, in 2017, the Department of Veterans Affairs paid prescription drug prices that were on average 54% lower than what was paid by Medicare, which by law is not currently allowed to negotiate down the prices that drugmakers choose […]

more info 01/15/2021View Related Articles
Bookmark and Share

Fierce JPM Week Partner Content Hub

This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. Here at Fierce JPM Week attendees can engage with digital assets in a way that is easy to navigate, learn from and share with peers and colleagues. This hub provides access to […]

more info 01/15/2021View Related Articles
Bookmark and Share

New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice

An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the burgeoning challenges posed by shrinking budgets, healthcare rationing, medication shortages, and an aging global population. The 2nd edition of Pharmacoeconomics: From […]

more info 01/14/2021View Related Articles
Bookmark and Share

New Data Show Retail Medicine Prices Fell in 2019

In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & Medicaid Services (CMS) published recently in Health Affairs. While retail prescription medicine spending grew 5.7% that same year, this […]

more info 01/14/2021View Related Articles
Bookmark and Share

Pandemic Propels Health Systems to Mull Acquisitions, Partnerships

Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems made a case for the need to accelerate toward value-based arrangements and potentially acquiring or partnering with health plans to become an integrated system. Amid new records for […]

more info 01/14/2021View Related Articles
Bookmark and Share

Gaps in Health Data are Barrier to Health Equity

COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites. Similarly, the rate of COVID-19 related deaths among Black Americans and American Indian/Alaskan […]

more info 01/14/2021View Related Articles
Bookmark and Share

Cerner Aspires to Build $1B Data Business in Pharma Market

Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building a $1 billion data business for the healthcare and life sciences industries. Cerner announced plans in December to acquire the health division of Kantar Group, which […]

more info 01/14/2021View Related Articles
Bookmark and Share

[Podcast] Creating an HEOR Function Within Medical Affairs

In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why a Medical Affairs organization needs an HEOR function and how to build this capability within Medical Affairs. This podcast is brought to you by AlphaGroup an independent […]

more info 01/13/2021View Related Articles
Bookmark and Share

Implications of Price Transparency for Providers and Patients as New Rules Go into Effect

A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common […]

more info 01/13/2021View Related Articles
Bookmark and Share

STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies

In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning and reporting on the implementation of real world evidence (RWE) studies of the safety and effectiveness of treatments. The template serves as […]

more info 01/13/2021View Related Articles
Bookmark and Share

Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals

Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers performed a study aiming to estimate the wage-and-salary earnings of a sample of health economics, outcomes research, and market access (HE/OR/MA) […]

more info 01/13/2021View Related Articles
Bookmark and Share

2021 ARM – Call for Abstracts

Present your work at the premier forum for health services researchers, policy analysts, clinicians and community leaders using evidence and data to improve health and health care for all. The 2021 Annual Research Meeting is organized around 21 themes and five submission types. All individual […]

more info 01/13/2021View Related Articles
Bookmark and Share

Specialty Generics Face Perverse Incentives In Medicare Part D

Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of rebates drugmakers are willing to offer to a pharmacy benefit manager (PBM) to secure preferred placement on the formulary. Originator firms can outmaneuver specialty […]

more info 01/12/2021View Related Articles
Bookmark and Share

Guest Blog Posts for the Journal of HEOR Website

The Journal of Health Economics and Outcomes Research is currently in the process of soliciting guest blog posts for the JHEOR web site and wanted to invite you to participate in this opportunity. We're seeking submissions on a range of topics related to HEOR and, in particular, right now, posts […]

more info 01/12/2021View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 117
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • Data removes the barriers to understanding rare disease
  • The Future Was Today
  • How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
  • Strategies for Engaging Vulnerable Populations in Healthcare
  • Tracing the health care experience informs decision-making
  • Driving More Value and Cost Savings With SDOH Data
  • Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
  • Transformation of Clinical Trial Design and Operations
  • Using real-world data to close the rare disease data gap
  • Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE
  • The role of real-world evidence in FDA approvals
  • Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
  • Specialty Pharmacy Virtual Technology Adoption on the Rise
  • Clinical Trials Have Changed. Has Your Tech Strategy?
  • Beyond COVID-19: Life sciences reimagined
  • How Real-World Evidence Can Support Adoption of New Technology
  • Interventional Studies
  • Virtual Expanded Access Program Providing Breast Cancer Patients Early Access to Treatment During the COVID-19 Pandemic
  • Pediatric Drug Development: Trends and Perspectives in the United States
  • Can Clinical Studies Go Virtual?
  • ICER’s impact on payer decision making
  • Representation and Diversity in Clinical Trials
  • Advisory Boards: The Good, The Bad, and The Ugly
  • An Initial Framework to Describe and Classify Integrated Scientific Advice Procedures
  • Ensuring timely dissemination of research: a guide to working as a medical publications professional
  • Patient Intelligence and Insights Reports
  • Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines
  • Patient Centricity
       Exploring the patient dynamic from different perspectives
  • How to Excel at Next Generation Trial Execution

Syndicated Reports

  • Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
  • Health Economics & Outcomes Research (HEOR) Services Market to 2027
  • Healthcare Artificial Intelligence Market by Product and Services – Global Forecast to 2027
  • Bioinformatics Market – Growth, Share, Opportunities & Competitive Analysis, 2020 – 2028
  • Big Data and AI in Market Access
  • Altruista Health Payer Index Survey 2020 Report
  • Innovations in Drug Pricing and Reimbursement 2020
  • Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
  • Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
  • Directory of Health Plans: Trusted Health Insurance Plan Enrollment and Affiliation Data
  • Global Value-Based Reimbursement Software Market Report
  • Health Economics & Outcomes Research (HEOR) Services Market: Emerging industries, Challenges and Threats Faced by Key Vendors(Axtria, Avalon Health Economics, Cardinal Health, ICON, IQVIA, McKesson, MEDLIOR, Optum, PharmaLex, (PPD), RTI)
  • World Preview 2019, Outlook to 2024
  • Provider Perceptions of Value-Based Care
  • Healthcare Industry’s Response to COVID-19
  • Value-Based Care Assessment
  • Pharmacy Benefit Management Market in US – Industry Outlook and Forecast 2020-2025
  • 2025 Growth: Healthcare Reimbursement Market set to grow with massive rate by 2020 to 2025
  • Global Specialty Pharmaceutical Market 2020- Pfizer, Roche, Amgen, AbbVie
  • 3 Trends to Accelerate Time to Market
  • Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery
  • Engaging with ICER: Lessons and insights for pharma
  • COVID-19 Implications for pharma: US payer insights
  • Pricing and Reimbursement in Oncology
  • Digital Technologies: New Strategies for Customer Engagement
  • Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024
  • 2019 Healthcare Benchmarks: Social Determinants of Health
  • Pricing Transparency in Pharma
  • Medical Affairs: The Roadmap to 2025
  • Health Economics & Outcomes Research (HEOR) Services Market Share & Forecast, 2020–2026
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute